Mice fed lipid-encapsulated Mycobacterium bovis BCG are protected against aerosol challenge with Mycobactenum tuberculosis

Infection and Immunity

Volumn 73, Issue 3, 2005, Pages 1903-1905

  Aldwell, Frank E ^a   Brandt, Lise ^b,c   Fitzpatrick, Clare ^a   Orme, Ian M ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c Symbion   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 2; LIPID;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIAL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENCAPSULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEEDING; FEMALE; IMMUNOGENICITY; LUNG HOMOGENATE; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; VACCINATION; ANIMAL; C57BL MOUSE; CATTLE; CHEMISTRY; IMMUNIZATION; IMMUNOLOGY; LUNG; LUNG TUBERCULOSIS; MICROBIOLOGY; MICROCAPSULE; ORAL DRUG ADMINISTRATION; PATHOGENICITY; SPLEEN;

ADMINISTRATION, ORAL; AEROSOLS; ANIMALS; BCG VACCINE; CAPSULES; CATTLE; IMMUNIZATION; LIPIDS; LUNG; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; SPLEEN; TUBERCULOSIS, PULMONARY;

EID: 15544384308     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.3.1903-1905.2005     Document Type: Article

References (16)

1. Aldwell, F. E., I. G. Tucker, G. W. de Lisle, and B. M. Buddle. 2003. Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice. Infect. Immun. 71:101-108.
2. Aldwell, F. E., D. Keen, N. Parlane, M. A. Skinner, G. W. de Lisle, and B. M. Buddle. 2003. Oral vaccination with Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in possums. Vaccine 22:70-76.
3. Chen, L., J. Wang, A. Zganiacz, and Z. Xing. 2004. Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis. Infect. Immun. 72:238-246.
4. Doherty, T. M., A. W. Olsen, L. van Pinxteren, and P. Andersen. 2002. Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis. Infect. Immun. 70:3111-3121.
5. Dolin, P. J., M. C. Raviglione, and A. Kochi. 1994. Global tuberculosis incidence and mortality during 1990-2000. Bull. W. H. O. 72:213-220.
6. Gheorghiu, M., M. Lagranderie, and A. M. Balazuc. 1996. Stabilisation of BCG vaccines. New approaches to stabilisation of vaccine potency. Dev. Biol. Stand. 87:251-261.
7. Hoft, D. F., R. M. Brown, and R. B. Belshe. 2000. Mucosal bacille Calmette-Guerin vaccination of humans inhibits delayed-type hypersensitivity to purified protein derivative but induces mycobacteria-specific interferon-gamma responses. Clin. Infect. Dis. 30(Suppl. 3):S217-S222.
8. Lagranderie, M., A. M. Balazuc, E. Deriaud, C. D. Leclerc, and M. Gheorghiu. 1996. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Infect. Immun. 64:1-9.
9. Lagranderie, M., P. Chavarot, A. M. Balazuc, and G. Marchal. 2000. Immunogenicity and protective capacity of Mycobacterium bovis BCG after oral or intragastric administration in mice. Vaccine 18:1186-1195.
10. Lima, K. M., S. A. Santos, V. M. Lima, A. A. Coelho-Castelo, J. M. Rodrigues, Jr., and C. L. Silva. 2003. Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis. Gene Ther. 10:678-685.
11. Manabe, Y. C., C. P. Scott, and W. R. Bisha. 2002. Naturally attenuated, orally administered Mycobacterium micron as a tuberculosis vaccine is better than subcutaneous Mycobacterium bovis BCG. Infect. Immun. 70:1566-1570.
12. Olsen, A. W., L. Brandt, E. M. Agger, L. A. Van Pinxteren, and P. Andersen. 2004. The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis. Scand. J. Immunol. 60:273-277.
13. Orme, I. M., and F. M. Collins. 1984. Efficacy of Mycobacterium bovis BCG vaccination in mice undergoing prior pulmonary infection with atypical mycobacteria. Infect. Immun. 44:28-32.
14. Skeiky, Y. A., M. R. Alderson, P. J. Ovendale, J. A. Guderian, L. Brandt, D. C. Dillon, A. Campos-Neto, Y. Lobet, W. Dalemans, I. M. Orme, and S. G. Reed. 2004. Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein. J. Immunol. 172:7618-7628.
15. Turner, J., M. Gonzalez-Juarrero, B. M. Saunders, J. V. Brooks, P. Marietta, D. L. Ellis, A. A. Frank, A. M. Cooper, and I. M. Orme. 2001. Immunological basis for reactivation of tuberculosis in mice. Infect. Immun. 69:3264-3270.
16. Williams, A., A. Davies, P. D. Marsh, M. A. Chambers, and R. G. Hewinson. 2000. Comparison of the protective efficacy of bacille Calmette-Guerin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis. Clin. Infect. Dis. 30(Suppl. 3):S299-S301.